Free Trial
Tada emoji MarketBeat All Access — Now Just $5.00 for 5 Weeks

BioMarin Pharmaceutical (BMRN) SEC Filings & 10K Form

BioMarin Pharmaceutical logo
$57.04 +0.24 (+0.42%)
As of 10:35 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.
Compare

Recent BioMarin Pharmaceutical SEC Filings

Export to Excel
DateFilerForm TypeView
08/05/2025
5:51 PM		BioMarin Pharmaceutical (Issuer)
CLARK IAN T (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/05/2025
5:55 PM		BioMarin Pharmaceutical (Issuer)
CLARK IAN T (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/05/2025
12:03 PM		BioMarin Pharmaceutical (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/01/2025
8:18 AM		BioMarin Pharmaceutical (Filed by)
Inozyme Pharma, Inc. (Subject)
Form SC TO-T/A
06/17/2025
6:28 AM		BioMarin Pharmaceutical (Filed by)
Inozyme Pharma, Inc. (Subject)
Form SC TO-T/A
06/04/2025
3:32 PM		BioMarin Pharmaceutical (Filed by)
Inozyme Pharma, Inc. (Subject)
Form SC TO-T/A
06/02/2025
5:25 AM		BioMarin Pharmaceutical (Filed by)
Inozyme Pharma, Inc. (Subject)
Form SC TO-T
05/20/2025
4:58 PM		BioMarin Pharmaceutical (Issuer)
Burkhart Erin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/20/2025
8:58 AM		BioMarin Pharmaceutical (Subject)
Burkhart Erin (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/19/2025
4:22 PM		BioMarin Pharmaceutical (Filed by)
Inozyme Pharma, Inc. (Subject)
Form SC TO-C
05/16/2025
8:44 PM		BioMarin Pharmaceutical (Filed by)
Inozyme Pharma, Inc. (Subject)
Form SC TO-C
05/16/2025
4:16 PM		BioMarin Pharmaceutical (Filed by)
Inozyme Pharma, Inc. (Subject)
Form SC TO-C
05/16/2025
6:54 AM		BioMarin Pharmaceutical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/16/2025
6:59 AM		BioMarin Pharmaceutical (Subject)
Form SC TO-C
05/13/2025
10:32 AM		BioMarin Pharmaceutical (Subject)
Capital Research Global Investors (Filed by)
Form SCHEDULE 13G/A
05/02/2025
11:33 AM		BioMarin Pharmaceutical (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/02/2025
9:05 AM		BioMarin Pharmaceutical (Subject)
Hubbard Cristin (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/29/2025
8:14 AM		BioMarin Pharmaceutical (Subject)
BlackRock, Inc. (Filed by)
Form SCHEDULE 13G/A
04/08/2025
3:09 PM		BioMarin Pharmaceutical (Filer)
Form DEF 14A
04/08/2025
3:12 PM		BioMarin Pharmaceutical (Filer)
Form DEFA14A
03/20/2025
6:38 PM		BioMarin Pharmaceutical (Issuer)
Burkhart Erin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2025
8:36 AM		BioMarin Pharmaceutical (Subject)
Burkhart Erin (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/18/2025
6:51 PM		BioMarin Pharmaceutical (Issuer)
Davis George Eric (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2025
6:53 PM		BioMarin Pharmaceutical (Issuer)
Burkhart Erin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2025
5:23 PM		BioMarin Pharmaceutical (Issuer)
Friberg Gregory R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2025
5:25 PM		BioMarin Pharmaceutical (Issuer)
Hubbard Cristin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2025
5:17 PM		BioMarin Pharmaceutical (Issuer)
Hardy Alexander (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2025
5:19 PM		BioMarin Pharmaceutical (Issuer)
Mueller Brian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2025
5:22 PM		BioMarin Pharmaceutical (Issuer)
Guyer Charles Greg (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
3:11 PM		BioMarin Pharmaceutical (Issuer)
Guyer Charles Greg (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2025
6:15 PM		BioMarin Pharmaceutical (Issuer)
Davis George Eric (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2025
6:17 PM		BioMarin Pharmaceutical (Issuer)
Guyer Charles Greg (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2025
6:19 PM		BioMarin Pharmaceutical (Issuer)
Mueller Brian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2025
3:18 PM		BioMarin Pharmaceutical (Issuer)
Walbert Timothy P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/25/2025
7:21 PM		BioMarin Pharmaceutical (Issuer)
Burkhart Erin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/24/2025
12:54 PM		BioMarin Pharmaceutical (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/24/2025
9:26 AM		BioMarin Pharmaceutical (Subject)
Burkhart Erin (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/19/2025
3:07 PM		BioMarin Pharmaceutical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/13/2025
1:14 PM		BioMarin Pharmaceutical (Subject)
Capital Research Global Investors (Filed by)
Form SCHEDULE 13G/A
12/03/2024
5:15 PM		BioMarin Pharmaceutical (Issuer)
Hardy Alexander (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/14/2024
1:44 PM		BioMarin Pharmaceutical (Issuer)
Guyer Charles Greg (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
The stealth altcoin the financial world is underestimating (Ad)

This DeFi project could soar next When altcoin season fully kicks in—which the data suggests is happening RIGHT NOW—this project is poised to see massive moves.... The smart money is already positioning.

Discover the protocol that's quietly replacing traditional finance.
11/12/2024
1:27 PM		BioMarin Pharmaceutical (Subject)
Guyer Charles Greg (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/31/2024
2:01 PM		BioMarin Pharmaceutical (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/01/2024
3:50 PM		BioMarin Pharmaceutical (Issuer)
Friberg Gregory R (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
10/01/2024
3:51 PM		BioMarin Pharmaceutical (Issuer)
Friberg Gregory R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/30/2024
3:29 PM		BioMarin Pharmaceutical (Subject)
VIKING GLOBAL INVESTORS LP (Filed by)
Form SC 13G
09/24/2024
7:31 AM		BioMarin Pharmaceutical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/17/2024
4:54 PM		BioMarin Pharmaceutical (Issuer)
FUCHS HENRY J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2024
11:52 AM		BioMarin Pharmaceutical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/28/2024
4:02 PM		BioMarin Pharmaceutical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/22/2024
4:00 PM		BioMarin Pharmaceutical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/13/2024
10:48 AM		BioMarin Pharmaceutical (Subject)
Burkhart Erin (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:BMRN) was last updated on 8/12/2025 by MarketBeat.com Staff
From Our Partners
When the levee breaks
The U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was project...
Porter & Company | Sponsored
Why Elon put $51 million into this
Chris Rowe has made legendary calls—Tesla at $13, Nvidia at $40, Bitcoin under $1,000, Amazon at 12 cents. Now...
True Market Insiders | Sponsored
Sell this, buy that
What you don’t own matters just as much as what you do. That’s the thinking behind Eric Fry’s long-time strate...
InvestorPlace | Sponsored
INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
Right now, we’re witnessing a monumental shift in the world.
Traders Agency | Sponsored
Musk’s Project Colossus could mint millionaires
I predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...
Brownstone Research | Sponsored
BONUS GUIDE - Ben Stein Prepares For the Next Financial Crisis
With inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...
Goldco Precious Metals | Sponsored
Genesis 14:13-17 [HIDDEN MEANING?]
A mysterious Bible verse from Genesis may hold the key to unlocking what one expert calls an “American birthri...
Paradigm Press | Sponsored
Sell these stocks now—what to buy instead
Wall Street veteran Marc Chaikin—creator of the Power Gauge system—is warning that “smart money” is rapidly pu...
Chaikin Analytics | Sponsored